[Type IV immunity in alopecia areata in a comparison of 2 test methods].
69 patients with alopecia areata of different degree and duration were tested for cell-mediated immunity (DCH) by means of the Multitest system and other recall antigens. Our findings revealed a normergic status in most of the patients. In comparison with healthy controls, however, these patients showed decreased cell-mediated immunity, which was proved by a diminished score and a reduced number of positive reactions. There was no correlation between an anergic or hypoergic status on the one hand, and the degree or duration of the disease on the other.
Lutz
G
G
Haut- und Poliklinik der Friedrich-Wilhelms-Universität Bonn.
Niedecken
H
H
Bauer
R
R
Kreysel
H W
HW
D000328:Adult; D000506:Alopecia Areata / Q000276:immunology*; D000941:Antigens / Q000276:immunology; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007156:Immunologic Memory; D007428:Intradermal Tests; D007958:Leukocyte Count; D008297:Male; D013601:T-Lymphocytes / Q000145:classification
D000941:Antigens
Die Typ-IV-Immunität der Alopecia areata im Vergleich zweier Testmethoden.